Evidence map›Paper›PMID 11950237›Full record

ArticleExperimental eye research2002

Heterologous expression of WT and mutant photoreceptor peripherin/rds in Madin Darby canine kidney cells: an assessment of fusogenic function.

Frank P Stefano, Jennifer Krouse, Peter Marta, Kathleen Boesze-Battaglia

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. An unconventional secretory pathway mediates the cilia targeting of peripherin/rds.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Photoreceptor renewal: a role for peripherin/rds.International review of cytology · 2002
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Frank P StefanoDepartment of Molecular Biology, University of Medicine and Dentistry of New Jersey-SOM, 2 Medical Center Drive, Stratford, NJ 08084, U.S.A.
Jennifer Krouse
Peter Marta
Kathleen Boesze-Battaglia
Stratford University · USRutgers, The State University of New Jersey · US

Funding

MEMBRANE FUSION IN RETINAL ROD OUTER SEGMENTSR01EY010420 · NEI · UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED · PI BOESZE-BATTAGLIA, KATHLEEN · 1999 to 2016
$4.7M
Nikon A1R confocal laser microscope system for live cell imagingS10RR026365 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI BOESZE-BATTAGLIA, KATHLEEN · 2010 to 2010
$500k
A Role for Melanoregulin in RPE-mediated PhagocytosisR21EY018705 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BOESZE-BATTAGLIA, KATHLEEN · 2009 to 2010
$437k
MEMBRANE FUSION IN RETINAL ROD OUTER SEGMENTSR29EY010420 · NEI · UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED · PI BOESZE-BATTAGLIA, KATHLEEN B · 1994 to 1998
–
NCRR NIH HHS S10 RR026365NEI NIH HHS EY 10420NEI NIH HHS R01 EY010420NEI NIH HHS R21 EY018705NEI NIH HHS R29 EY010420
6 · The paper itself

Abstract

Peripherin/rds is proposed to function as a fusion protein within the rod outer segment and a fusion domain has been mapped to amino acids 311-325 within the C-terminus. To map regions within peripherin/rds required for membrane fusion a series of C-terminal mutants was analyzed. Madin Darby canine kidney cells were transiently transfected with an Xpress or FLAG epitope tagged peripherin/rds (wt) and three mutants of peripherin/rds. The mutants selected were a P296T mutant (replacement of the proline at position 296 with a threonine) and two C-terminal deletion mutants (one lacking the terminal 10 amino acids, Delta10 and one lacking the terminal 50 amino acids, Delta50). The wt protein, the P296T and Delta10 mutants were detected on SDS-PAGE as 84 kDa dimers, that resolved into 38-42 kDa monomers under reducing conditions. The Delta50 mutant showed a slightly increased mobility. The cellular localization of mutants differed from that of wt peripherin/rds. The wt Xpress-human and wt FLAG-bovine peripherin/rds were localized to both intracellular and plasma membranes. In contrast, the C-terminal deletion mutants were localized only to the intracellular membrane. The P296T mutant presented a still different pattern: initially the protein localized to intracellular membranes. Upon confluence, however, the localization appeared to become predominantly plasma membrane. To assess the fusion activity of the proteins, the cell membranes were fractionated using sucrose density gradient centrifugation and the various fractions identified based on immunoreactivity in Western blot analysis with Golgi (anti-rab 6) or plasma membrane (anti-ZO-3) specific marker proteins. All membrane fractions were assayed for fusion with ROS plasma membrane vesicles. The plasma membrane enriched fractions (isolated at densities of 1.08 and 1.125 g ml(-1)) containing tagged peripherin/rds and the Delta10 mutant promoted membrane fusion with ROS plasma membrane vesicles. In contrast, fusion was not detected with plasma membrane vesicles from mock-transfected cells or the Delta50 peripherin/rds deletion mutant. Fusion was enhanced in a less dense fraction enriched in the P296T mutant (isolated from the 1.04/1.02 interface) relative to wt. Fusion was dependent on the presence of peripherin/rds in the membranes and could be inhibited with trypsinolysis and competition studies with the bovine fusion peptide, PP-5. Peptide competition suggests that the fusion domain of human peripherin/rds is most likely identical to that characterized in bovine and corresponds to amino acid residues 312-326. The C-terminal deletion mutants have allowed us to predict the minimal region of the C-terminus necessary for fusion to include residues starting at number 335. In addition a second region important in the formation of a fusion competent peripherin/rds has been mapped to a region upstream of the fusion peptide domain.

Indexed as

Membrane GlycoproteinsPoint MutationAnimalsCattleCell LineCell MembraneDogsGenetic EngineeringHumansImmunohistochemistryIntermediate Filament ProteinsKidneyMembrane FusionMicroscopy, ConfocalNerve Tissue ProteinsPeripherinsIntermediate Filament ProteinsMembrane GlycoproteinsNerve Tissue ProteinsPeripherinsPRPH2 protein, humanPRPH protein, human

Identifiers

PMID11950237
PMCPMC4746730
OpenAlexW2078385754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.